Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

targeted

targeted is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 48
News articles 0
Drug details — targeted
Class
—
Route
—
Patents
20
Programs
48
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

targeted is an FDA-listed pharmaceutical active ingredient.

Key facts

INN targeted

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. BO29554 Phase 3 · HOFFMANN-LA ROCHE · Advanced or metastatic Non-small cell lung cancer (NSCLC)
  2. CA088-1007 Phase 3 · Celgene · Relapsed or Refractory and Lenalidomide exposed Multiple Mye
  3. BCMA targeted prime CAR-T cells Phase 2 · Chongqing Precision Biotech · Multiple Myeloma
  4. CA061-1011 Phase 2 · Celgene · Lupus Nephritis, Systemic Lupus Erythematosus
  5. CAAA617H12101 Phase 2 · Novartis India · Metastatic neuroendocrine prostate cancer
  6. CD123 targeted CAR-NK cells Phase 2 · Chongqing Precision Biotech · Acute Myeloid Leukemia
  7. CD19 and CD22 targeted CAR-T cells Phase 2 · Chongqing Precision Biotech · Leukemia, B-cell
  8. CD19 and CD22 targeted prime CAR- T cells Phase 2 · Chongqing Precision Biotech · B Cell Lymphoma

Related patents

Browse patents

  1. US 12427148

    Cancer treatment targeted to tumor adaptive responses to protein synthesis stress

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12421315

    CLL-1 targeted immunotherapies

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12410259

    CD47 targeted therapies for the treatment of infectious disease

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12359220

    Guided magnetic nanostructures for targeted and high-throughput intracellular delivery

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12325755

    Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12303602

    Compositions, methods and uses for thermally stable multi-targeted antigens

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12290505

    Tissue factor-targeted antibody-drug conjugate

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12264187

    Compositions and methods for targeted therapeutic delivery to bone

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12257247

    Targeted degradation of VAV1

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12234461

    Targeted non-viral DNA insertions

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12221607

    Multi-targeted single entity conjugates

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12215162

    BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12209256

    System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12209142

    SARS-CoV-2 epitope-targeted peptide immunostimulants

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12195558

    Targeted delivery system and methods of use therefor

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12157735

    Compounds for targeted degradation of BRD9

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12084497

    SIRP1α targeted chimeric proteins and uses thereof

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12049464

    Compounds for targeted degradation of BRD9

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12043833

    Targeted compositions

    Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12031133

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is targeted?

targeted is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.